ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
GX Acquisition Corporation

GX Acquisition Corporation (GXGX)

10.20
0.00
( 0.00% )
Updated: 20:00:00

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
10.20
Bid
10.24
Ask
10.34
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
10.20
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
144,524,000
Dividend Yield
-
PE Ratio
103.87
Earnings Per Share (EPS)
0.1
Revenue
17.98M
Net Profit
14.19M

About GX Acquisition Corporation

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970

GXGX Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 25.06
(427.58%)
13.17M
XLOXilio Therapeutics Inc
$ 1.57
(145.70%)
19.94M
BDRXBiodexa Pharmaceuticals PLC
$ 1.5347
(78.66%)
56.17M
OTRKOntrak Inc
$ 1.0201
(71.45%)
13.75M
BCGBinah Capital Group Inc
$ 13.67
(43.89%)
325.31k
PMECPrimech Holdings Ltd
$ 1.99
(-48.71%)
1.62M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
QHQuhuo Ltd
$ 0.4121
(-28.03%)
1.15M
GMDAGamida Cell Ltd
$ 0.04335
(-26.77%)
31.95M
UGROUrban Gro Inc
$ 1.3788
(-24.03%)
269.4k
NKLANikola Corporation
$ 1.06
(16.60%)
76.45M
BDRXBiodexa Pharmaceuticals PLC
$ 1.532
(78.35%)
56.17M
AKANAkanda Corporation
$ 0.2261
(37.11%)
47.85M
CISSC3is Inc
$ 0.0338
(-11.52%)
32.67M
GMDAGamida Cell Ltd
$ 0.04335
(-26.77%)
31.95M

GXGX Discussion

View Posts
Pedro2004 Pedro2004 3 years ago
Every time this starts to run...they dump shares.
👍️0
crudeoil24 crudeoil24 3 years ago
Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ: GXGX), giving Celularity $138 million to push the NK cell and T cell therapies into early-stage trials.
The combined company will operate under the name Celularity Inc (NASDAQ: CELU), and its common stock will commence trading on the NASDAQ from Monday (19 July) under the ticker symbol CELU.
The company expanded its ongoing Phase 1 trial of CYNK-001 in patients with acute myeloid leukemia (AML)to include patients with relapsed/refractory AML (r/r AML) in addition to its ongoing trial in measurable residual disease (MRD).
To date, no dose-limiting toxicity was observed with outpatient administration of three doses.
The FDA granted Orphan Drug Designation to CYNK-001 for the treatment of patients with malignant gliomas.
CYNK-001 is currently in a Phase 1 trial for glioblastoma multiforme.
For Phase 1/2 COVID-19 trial assessing CYNK-001, no evidence of dose-limiting toxicities or evidence of no worsening inflammatory biomarkers was observed, and enrollment is ongoing.
👍️0
crudeoil24 crudeoil24 3 years ago
GXGX will be trading on the Nasdaq Capital Market on July 19, 2021, under the ticker symbol "CELU." Celularity's management team will continue leading the merged company following this transaction.
👍️0
ChickenHawk0-001avg ChickenHawk0-001avg 3 years ago
https://celularity.com/celularity-and-gx-acquisition-corp-announce-merger-agreement-to-create-a-publicly-listed-leader-in-allogeneic-cellular-therapy/

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy – Celularity
👍️0
ChickenHawk0-001avg ChickenHawk0-001avg 3 years ago
Just bought 1,000 shares today. This company looks great. It should have a steady increase short term.
👍️0
ChickenHawk0-001avg ChickenHawk0-001avg 3 years ago
If you are deciding to buy this mid to high risk stock, GXGX, here is what they are.

Click on link below and listen to broadcast.

Joint Investor Conference Call – Celularity
https://celularity.com/joint-investor-conference-call/
👍️0

Your Recent History

Delayed Upgrade Clock